Product Name: ARL6IP5 Antibody
Species Reactivity: Human, Mouse
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 22 kDa
Immunogen: This ARL6IP5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 70-99 amino acids from the Central region of human ARL6IP5.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 69839-83-4
Product: Didox
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: PRA1 family protein 3, ADP-ribosylation factor-like protein 6-interacting protein 5, ARL-6-interacting protein 5, Aip-5, Cytoskeleton-related vitamin A-responsive protein, Dermal papilla-derived protein 11, GTRAP3-18, Glutamate transporter EAAC1-interacting protein, JM5, Prenylated Rab acceptor protein 2, Protein JWa, Putative MAPK-activating protein PM27, ARL6IP5, DERP11, JWA, PRA2, PRAF3
Accession NO.: O75915
Protein Ino:
Official Symbol: ARL6IP5
Geneid: 10550
Background: Expression of this gene is affected by vitamin A. Theencoded protein of this gene may be associated with thecytoskeleton. A similar protein in rats may play a role in theregulation of cell differentiation. The rat protein binds andinhibits the cell membrane glutamate transporter EAAC1. Theexpression of the rat gene is upregulated by retinoic acid, whichresults in a specific reduction in EAAC1-mediated glutamatetransport.
PubMed ID:http://aac.asm.org/content/53/5/2181.abstract
